Pipeline

Visionary therapies are within reach

Candidates

Discovery

PreClinical

Phase 1

Phase 2

Pivotal

MDNA55

Recurrent GBM

Discovery | PreClinical | Phase 1 | Phase 2 | Pivotal

MDNA11

Cancer immunotherapies

Discovery | PreClinical | Phase 1 | Phase 2 | Pivotal

MDNA209

Autoimmune Diseases

Discovery | PreClinical | Phase 1 | Phase 2 | Pivotal

MDNA413

Cancer immunotherapies

Discovery | PreClinical | Phase 1 | Phase 2 | Pivotal

MDNA132

Solid Tumors: IL 13Ralpha2

Discovery | PreClinical | Phase 1 | Phase 2 | Pivotal